Form 4: Tenet Healthcare CEO Saumya Sutaria Reports Stock Grant After Performance Goals Met

Saumya Sutaria, CEO of Tenet Healthcare, reports the acquisition of 126,203 shares of common stock following the achievement of performance-based restricted stock targets.

Summary

• On February 11, 2025, Saumya Sutaria, CEO of Tenet Healthcare Corp, reported a transaction involving the acquisition of 126,203 shares of common stock.
• These shares were acquired as a result of performance-based restricted stock that was earned after the Human Resources Committee certified the achievement of applicable performance targets.
• The performance period for these targets was from January 1, 2022, to December 31, 2024.
• Following this transaction, Sutaria directly owns 397,724 shares of Tenet Healthcare Corp.
• The report was filed on February 13, 2025, by Chad J. Wiener as Attorney-in-fact for Saumya Sutaria.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The vesting of performance-based stock indicates that the company met certain performance goals, which is generally a positive sign. However, it's a routine disclosure and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The vesting of performance-based restricted stock suggests that performance goals were met, which could be viewed positively by investors.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Tenet Healthcare.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity grants to align management's interests with those of shareholders.
• The specific performance metrics and vesting schedules vary widely across the healthcare industry and are typically benchmarked against peer companies.

Stakeholder Impact

• The stock grant to the CEO aligns her interests with shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates